
FDA vaccine advisers vote to recommend Pfizer’s COVID-19 vaccine for children 5 to 11
Members of the FDA’s Vaccines and Related Biological Products Advisory Committee agreed that the benefits of vaccinating younger children appeared to outweigh the risks.